Comparison of Primary Orchiectomy and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Cancer
- 1 July 1990
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 66 (1) , 94-97
- https://doi.org/10.1111/j.1464-410x.1990.tb14872.x
Abstract
The primary clinical efficacy of orchiectomy and polyoestradiol phosphate (PEP) 160 mg/month i.m. was evaluated by progression and cancer mortality rates in Finnish multicentre study comprising 200 prostatic cancer patients. After the minimum follow-up time of 2 years there was a significant difference between the groups-orchiectomy delayed progression of the disease more effectively. The follow-up time is rather short for prostatic cancer, but on the basis of this preliminary study the dose of PEP seems to be insufficient in the treatment of advanced prostatic cancer.This publication has 8 references indexed in Scilit:
- High Dose Polyoestradiol Phosphate with and without Acetosalicylic Acid versus Orchiectomy in the Treatment of Prostatic CancerBritish Journal of Urology, 1989
- Plasma Concentrations of Estradiol and Testosterone in Single-Drug Polyestradiol Phosphate Therapy for Prostatic CancerEuropean Urology, 1987
- Steroid‐sensitive proteins, growth hormone and somatomedin C in prostatic cancer: Effects of parenteral and oral estrogen therapyThe Prostate, 1986
- Comparison of Primary Orchiectomy with Oestrogen Therapy in Advanced Prostatic Cancer; A 2‐Year Follow‐up Report of a National, Prospective Prostatic Cancer StudyBritish Journal of Urology, 1986
- Treatment response criteria for prostatic cancerThe Prostate, 1984
- Hormonal Therapy of Prostatic CancerCancer, 1980
- Treatment of Prostatic Carcinoma with Polyestradiol Phosphate Combined with EthinylestradiolScandinavian Journal of Urology and Nephrology, 1971